CN104144916A - 二氢喹唑啉衍生物的苯磺酸盐和甲苯磺酸盐和其作为抗病毒剂的用途 - Google Patents
二氢喹唑啉衍生物的苯磺酸盐和甲苯磺酸盐和其作为抗病毒剂的用途 Download PDFInfo
- Publication number
- CN104144916A CN104144916A CN201380011791.1A CN201380011791A CN104144916A CN 104144916 A CN104144916 A CN 104144916A CN 201380011791 A CN201380011791 A CN 201380011791A CN 104144916 A CN104144916 A CN 104144916A
- Authority
- CN
- China
- Prior art keywords
- phenyl
- salt
- trifluoromethyl
- fluoro
- dihydroquinazoline
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/78—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 2
- C07D239/84—Nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
- C07C309/01—Sulfonic acids
- C07C309/28—Sulfonic acids having sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C309/29—Sulfonic acids having sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton of non-condensed six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
- C07C309/01—Sulfonic acids
- C07C309/28—Sulfonic acids having sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C309/29—Sulfonic acids having sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton of non-condensed six-membered aromatic rings
- C07C309/30—Sulfonic acids having sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton of non-condensed six-membered aromatic rings of six-membered aromatic rings substituted by alkyl groups
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Communicable Diseases (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims (15)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102012101673.9 | 2012-02-29 | ||
DE102012101673A DE102012101673A1 (de) | 2012-02-29 | 2012-02-29 | Salze eines Dihydrochinazolinderivats |
PCT/EP2013/054109 WO2013127968A1 (de) | 2012-02-29 | 2013-02-28 | Besylat- und tosylatsalze eines dihydrochinazolinderivates und ihre verwendung als antivirale mittel |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104144916A true CN104144916A (zh) | 2014-11-12 |
CN104144916B CN104144916B (zh) | 2016-08-24 |
Family
ID=47884256
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201380011791.1A Active CN104144916B (zh) | 2012-02-29 | 2013-02-28 | 二氢喹唑啉衍生物的苯磺酸盐和甲苯磺酸盐和其作为抗病毒剂的用途 |
Country Status (19)
Country | Link |
---|---|
US (4) | US9512085B2 (zh) |
EP (1) | EP2820000B1 (zh) |
JP (1) | JP6235493B2 (zh) |
CN (1) | CN104144916B (zh) |
CA (1) | CA2865534C (zh) |
CY (1) | CY1118284T1 (zh) |
DE (1) | DE102012101673A1 (zh) |
DK (1) | DK2820000T3 (zh) |
ES (1) | ES2583360T3 (zh) |
HK (1) | HK1205511A1 (zh) |
HR (1) | HRP20160886T1 (zh) |
HU (1) | HUE027751T2 (zh) |
LT (1) | LT2820000T (zh) |
PL (1) | PL2820000T3 (zh) |
PT (1) | PT2820000T (zh) |
RS (1) | RS54989B1 (zh) |
SI (1) | SI2820000T1 (zh) |
SM (1) | SMT201600343B (zh) |
WO (1) | WO2013127968A1 (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113880776A (zh) * | 2021-11-16 | 2022-01-04 | 山东诚创蓝海医药科技有限公司 | 一种莱特莫韦中间体的制备方法 |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10319612A1 (de) | 2003-05-02 | 2004-11-18 | Bayer Healthcare Ag | Substituierte Dihydrochinazoline |
DE102012101673A1 (de) | 2012-02-29 | 2013-08-29 | Aicuris Gmbh & Co. Kg | Salze eines Dihydrochinazolinderivats |
DE102012101659A1 (de) * | 2012-02-29 | 2013-08-29 | Aicuris Gmbh & Co. Kg | Salze eines Dihydrochinazolinderivats |
RS58882B1 (sr) * | 2013-06-19 | 2019-08-30 | Aicuris Anti Infective Cures Gmbh | Amorfni letermovir i njegove čvrste farmaceutske formulacije za oralno davanje |
WO2015088931A1 (en) * | 2013-12-12 | 2015-06-18 | Merck Sharp & Dohme Corp. | Process for making substituted quinazoline compounds |
WO2017091453A1 (en) * | 2015-11-24 | 2017-06-01 | Merck Sharp & Dohme Corp. | Novel processes for making substituted quinazoline compounds using hydrogen bonding catalysts |
EP3753942B1 (en) * | 2018-02-08 | 2024-01-03 | Phaeno Therapeutics Co., Ltd. | Crystal form of 3,4-dihydrothieno[3,2-d]pyrimidine compound and preparation method therefor |
IT202000017617A1 (it) | 2020-07-21 | 2022-01-21 | Olon Spa | Procedimento per la preparazione di un intermedio utilizzato nella sintesi del letermovir |
US20230312485A1 (en) | 2020-08-17 | 2023-10-05 | Lupin Limited | A precipitation process for amorphous letermovir |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1784390A (zh) * | 2003-05-02 | 2006-06-07 | 拜耳医药保健股份公司 | 具有抗病毒性能的取代二氢喹唑啉 |
US20070281953A1 (en) * | 2003-11-11 | 2007-12-06 | Bayer Healthcare Ag | Substituted Dihydroquinazolines II |
CN101863843A (zh) * | 2005-06-15 | 2010-10-20 | 艾库里斯有限及两合公司 | 制备二氢喹唑啉的方法 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102011101446A1 (de) | 2011-05-10 | 2012-11-15 | Aicuris Gmbh & Co. Kg | Herstellung von "Dense Bodies" (DB) |
DE102012101673A1 (de) | 2012-02-29 | 2013-08-29 | Aicuris Gmbh & Co. Kg | Salze eines Dihydrochinazolinderivats |
DE102012101659A1 (de) | 2012-02-29 | 2013-08-29 | Aicuris Gmbh & Co. Kg | Salze eines Dihydrochinazolinderivats |
RS58882B1 (sr) | 2013-06-19 | 2019-08-30 | Aicuris Anti Infective Cures Gmbh | Amorfni letermovir i njegove čvrste farmaceutske formulacije za oralno davanje |
-
2012
- 2012-02-29 DE DE102012101673A patent/DE102012101673A1/de not_active Ceased
-
2013
- 2013-02-28 PT PT137093456T patent/PT2820000T/pt unknown
- 2013-02-28 RS RS20160574A patent/RS54989B1/sr unknown
- 2013-02-28 ES ES13709345.6T patent/ES2583360T3/es active Active
- 2013-02-28 JP JP2014559231A patent/JP6235493B2/ja active Active
- 2013-02-28 HU HUE13709345A patent/HUE027751T2/en unknown
- 2013-02-28 DK DK13709345.6T patent/DK2820000T3/en active
- 2013-02-28 SI SI201330242A patent/SI2820000T1/sl unknown
- 2013-02-28 EP EP13709345.6A patent/EP2820000B1/de active Active
- 2013-02-28 US US14/381,625 patent/US9512085B2/en active Active
- 2013-02-28 PL PL13709345T patent/PL2820000T3/pl unknown
- 2013-02-28 CA CA2865534A patent/CA2865534C/en active Active
- 2013-02-28 CN CN201380011791.1A patent/CN104144916B/zh active Active
- 2013-02-28 WO PCT/EP2013/054109 patent/WO2013127968A1/de active Application Filing
- 2013-02-28 LT LTEP13709345.6T patent/LT2820000T/lt unknown
-
2015
- 2015-06-25 HK HK15106079.4A patent/HK1205511A1/zh unknown
-
2016
- 2016-07-15 HR HRP20160886TT patent/HRP20160886T1/hr unknown
- 2016-07-18 CY CY20161100699T patent/CY1118284T1/el unknown
- 2016-09-30 SM SM201600343T patent/SMT201600343B/it unknown
- 2016-10-31 US US15/338,984 patent/US10287254B2/en not_active Ceased
-
2017
- 2017-07-03 US US15/640,661 patent/US20170362186A1/en not_active Abandoned
-
2021
- 2021-05-14 US US17/320,587 patent/USRE49897E1/en active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1784390A (zh) * | 2003-05-02 | 2006-06-07 | 拜耳医药保健股份公司 | 具有抗病毒性能的取代二氢喹唑啉 |
US20070281953A1 (en) * | 2003-11-11 | 2007-12-06 | Bayer Healthcare Ag | Substituted Dihydroquinazolines II |
CN101863843A (zh) * | 2005-06-15 | 2010-10-20 | 艾库里斯有限及两合公司 | 制备二氢喹唑啉的方法 |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113880776A (zh) * | 2021-11-16 | 2022-01-04 | 山东诚创蓝海医药科技有限公司 | 一种莱特莫韦中间体的制备方法 |
Also Published As
Publication number | Publication date |
---|---|
US20170362186A1 (en) | 2017-12-21 |
LT2820000T (lt) | 2016-11-10 |
DK2820000T3 (en) | 2016-07-25 |
CN104144916B (zh) | 2016-08-24 |
US20150045371A1 (en) | 2015-02-12 |
HRP20160886T1 (hr) | 2016-09-23 |
JP6235493B2 (ja) | 2017-11-22 |
EP2820000A1 (de) | 2015-01-07 |
CA2865534C (en) | 2019-04-02 |
CA2865534A1 (en) | 2013-09-06 |
SMT201600343B (zh) | 2016-11-10 |
US10287254B2 (en) | 2019-05-14 |
RS54989B1 (sr) | 2016-11-30 |
US20170114026A1 (en) | 2017-04-27 |
PT2820000T (pt) | 2016-07-20 |
PL2820000T3 (pl) | 2017-07-31 |
JP2015508800A (ja) | 2015-03-23 |
WO2013127968A1 (de) | 2013-09-06 |
ES2583360T3 (es) | 2016-09-20 |
HUE027751T2 (en) | 2016-10-28 |
DE102012101673A1 (de) | 2013-08-29 |
USRE49897E1 (en) | 2024-04-02 |
US9512085B2 (en) | 2016-12-06 |
HK1205511A1 (zh) | 2015-12-18 |
EP2820000B1 (de) | 2016-04-20 |
SI2820000T1 (sl) | 2016-08-31 |
CY1118284T1 (el) | 2017-06-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104144916A (zh) | 二氢喹唑啉衍生物的苯磺酸盐和甲苯磺酸盐和其作为抗病毒剂的用途 | |
CN104144917B (zh) | 二氢喹唑啉衍生物的钠盐和钙盐及其作为抗病毒剂的用途 | |
CN104144678A (zh) | 含有抗病毒活性二氢喹唑啉衍生物的药物制剂 | |
AU2014209319B2 (en) | Crystalline forms of {[1-cyano-5-(4-chlorophenoxy)-4-hydroxy-isoquinoline-3-carbonyl]-amino}-acetic acid | |
CN108250122A (zh) | 磺酰胺-芳基酰胺类化合物及其治疗乙型肝炎的药物用途 | |
CN113527293B (zh) | Kras g12c突变蛋白抑制剂及其药物组合物、制备方法和用途 | |
EP3873607B1 (en) | Quinazolinyl-indazole derivatives and their use as inhibitors of human immunodeficiency virus replication | |
KR20030069796A (ko) | 졸피뎀 헤미타르트레이트 | |
EP2269994B1 (en) | The polymorphs of 4-anilinoquinazoline derivatives, the preparation methods and uses thereof | |
CN103601762A (zh) | 二茂铁衍生物、制备方法及其用途 | |
WO2018010622A1 (zh) | 化合物的晶型及其制备方法、组合物和应用 | |
WO2018028491A1 (zh) | 吲哚胺2,3-双加氧酶抑制剂及其在药学中的用途 | |
US20170037005A1 (en) | Solid forms of a pharmaceutically active compound | |
CN113788835B (zh) | 一种含吗啉和喹啉环的三唑并四嗪类化合物及其制备方法和应用 | |
WO2014193881A1 (en) | Crystalline form of n,n-dicyclopropyl-4-(1,5-dimethyl-1 h-pyrazol-3-ylamino)-6-ethyl-1 -methyl-1,6-dihyrdroimidazo[4,5-d]pyrrolo[2,3-b]pyridine-7-carboxamide for the treatment of myeloproliferative disorders | |
CN114014856B (zh) | 作为呼吸道合胞病毒抗病毒剂的咪唑并吡啶类衍生物 | |
CN114573581A (zh) | 5-取代氨基-1,3-二取代苯基吡啶并[2,3-d]嘧啶类化合物及其制备与应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20190116 Address after: Germany Wuppertal Patentee after: AICURIS ANTI-INFECTIVE CURES GmbH Address before: Germany Wuppertal Patentee before: AICURIS GmbH & Co.KG |
|
TR01 | Transfer of patent right | ||
CP01 | Change in the name or title of a patent holder |
Address after: Germany Wuppertal Patentee after: AIC246 JSC Address before: Germany Wuppertal Patentee before: AIC246 Lianghe Co. |
|
CP01 | Change in the name or title of a patent holder | ||
TR01 | Transfer of patent right |
Effective date of registration: 20221027 Address after: Germany Wuppertal Patentee after: AIC246 Lianghe Co. Address before: Germany Wuppertal Patentee before: AICURIS ANTI-INFECTIVE CURES GmbH |
|
TR01 | Transfer of patent right |